Dental Implantation — Clinical and Histological Evaluation of Healos® for Alveolar Ridge Augmentation
Citation(s)
Basa S, Varol A, Turker N Alternative bone expansion technique for immediate placement of implants in the edentulous posterior mandibular ridge: a clinical report. Int J Oral Maxillofac Implants. 2004 Jul-Aug;19(4):554-8.
Buser DA, Tonetti M Clinical trials on implants in regenerated bone. Ann Periodontol. 1997 Mar;2(1):329-42. Review.
Coatoam GW, Mariotti A The segmental ridge-split procedure. J Periodontol. 2003 May;74(5):757-70.
MURRAY G, HOLDEN R, ROSCHLAU W Experimental and clinical study of new growth of bone in a cavity. Am J Surg. 1957 Mar;93(3):385-7.
Neen D, Noyes D, Shaw M, Gwilym S, Fairlie N, Birch N Healos and bone marrow aspirate used for lumbar spine fusion: a case controlled study comparing healos with autograft. Spine (Phila Pa 1976). 2006 Aug 15;31(18):E636-40.
Ramfjord SP, Engler WO, Hiniker JJ A radioautographic study of healing following simple gingivectomy. II. The connective tissue. J Periodontol. 1966 May-Jun;37(3):179-89.
Simion M, Baldoni M, Zaffe D Jawbone enlargement using immediate implant placement associated with a split-crest technique and guided tissue regeneration. Int J Periodontics Restorative Dent. 1992;12(6):462-73.
Clinical and Histological Evaluation of Healos® for Alveolar Ridge Augmentation
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
